๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosis

โœ Scribed by Floyd A. Davis; Dusan Stefoski; Fred N. Quandt

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
124 KB
Volume
37
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Methotrexate in the treatment of multipl
Methotrexate in the treatment of multiple sclerosis
โœ Michael J. Olek; Marika J. Hohol; Howard L. Weiner ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB ๐Ÿ‘ 2 views
Monoclonal antibody treatment exposes th
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
โœ Alasdair J. Coles; Mark G. Wing; Paul Molyneux; Andrea Paolillo; Charlie M. Davi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 1 views

The elective treatment of patients with multiple sclerosis, using a humanized anti-leukocyte (CD52) monoclonal antibody (Campath-1H), has illuminated mechanisms that underlie the clinical course of the disease. Twenty-seven patients were studied clinically and by magnetic resonance imaging (MRI) bef